Synthesis 2014; 46(22): 3047-3058
DOI: 10.1055/s-0034-1378653
paper
© Georg Thieme Verlag Stuttgart · New York

A Practical Synthesis of a Potent and Selective Diacylglycerol Acyltransferase-1 (DGAT-1) Inhibitor

Authors

  • Youngsook Shin

    Department of Therapeutic Discovery, Amgen Inc., 1120 Veterans Boulevard, South San Francisco, CA 94080, USA   Fax: +1(650)8379369   Email: tcushing@amgen.com
  • Philippe Bergeron

    Department of Therapeutic Discovery, Amgen Inc., 1120 Veterans Boulevard, South San Francisco, CA 94080, USA   Fax: +1(650)8379369   Email: tcushing@amgen.com
  • Brian M. Fox

    Department of Therapeutic Discovery, Amgen Inc., 1120 Veterans Boulevard, South San Francisco, CA 94080, USA   Fax: +1(650)8379369   Email: tcushing@amgen.com
  • Frank Kayser

    Department of Therapeutic Discovery, Amgen Inc., 1120 Veterans Boulevard, South San Francisco, CA 94080, USA   Fax: +1(650)8379369   Email: tcushing@amgen.com
  • Lawrence R. McGee

    Department of Therapeutic Discovery, Amgen Inc., 1120 Veterans Boulevard, South San Francisco, CA 94080, USA   Fax: +1(650)8379369   Email: tcushing@amgen.com
  • Sharon McKendry

    Department of Therapeutic Discovery, Amgen Inc., 1120 Veterans Boulevard, South San Francisco, CA 94080, USA   Fax: +1(650)8379369   Email: tcushing@amgen.com
  • Dustin L. McMinn

    Department of Therapeutic Discovery, Amgen Inc., 1120 Veterans Boulevard, South San Francisco, CA 94080, USA   Fax: +1(650)8379369   Email: tcushing@amgen.com
  • Marc Labelle

    Department of Therapeutic Discovery, Amgen Inc., 1120 Veterans Boulevard, South San Francisco, CA 94080, USA   Fax: +1(650)8379369   Email: tcushing@amgen.com
  • Timothy D. Cushing*

    Department of Therapeutic Discovery, Amgen Inc., 1120 Veterans Boulevard, South San Francisco, CA 94080, USA   Fax: +1(650)8379369   Email: tcushing@amgen.com
Further Information

Publication History

Received: 12 June 2014

Accepted: 21 July 2014

Publication Date:
25 August 2014 (online)


Graphical Abstract

Preview

Abstract

A practical synthesis of a potent, selective, and orally efficacious diacylglycerol acyltransferase-1 (DGAT-1) inhibitor, is described. This synthesis is suitable for multi-kilogram scale with high regioselectivity and stereoselectivity. The synthesis involves a Knoevenagel condensation with Meldrum’s acid followed by the stereoselective addition of phenyl cuprate, regioselective Friedel–Crafts acylation, cyclization, and a regioselective reduction through an enol triflate with catalytic platinum oxide to provide the desired compound in 5.2% yield over 12 steps.